Stephen Stripling, MD, FAAP, Discusses Study of Berdazimer Gel for Molluscum Contagiosum

Results published in the Journal of the American Medical Association (JAMA) Dermatology detailed the efficacy and safety of berdazimer gel 10.3%, in the treatment of molluscum contagiosum.

With no current FDA-approved treatments for molluscum contagiosum, Stephen Stripling, MD, FAAP, and co-medical director at Coastal Pediatric Research in Charleston, South Carolina, explains the importance of the JAMA berdazimer gel 10.3% study1 and the hope it provides for patients and their families.

Reference:

  1. Browning JC, Enloe C, Cartwright M, et al. Efficacy and Safety of Topical Nitric Oxide−Releasing Berdazimer Gel in Patients With Molluscum Contagiosum: A Phase 3 Randomized Clinical Trial. JAMA Dermatol. Published online July 13, 2022. doi:10.1001/jamadermatol.2022.2721